Schrodinger is trading at $19.76 (+5.27%) with no new company-specific announcement or analyst action clearly explaining the gain on August 25, 2026.

  • Recent coverage remains focused on August 5 earnings and the Bristol Myers Squibb AI collaboration.
  • The broader market is modestly higher, but gains remain below the threshold for a strong market-wide explanation.
  • Intraday activity is active, with no reliable volume figure provided.